The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma BPC 157 TB 500 Thrive Bio Lab FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Establishing a Robust Quality System in a 503B Outsourcing Facility American Pharmaceutical Review